The Efficacy and Safety of PD-1 Inhibitors Combined with Nab-Paclitaxel Plus Gemcitabine versus Nab-Paclitaxel Plus Gemcitabine in the First-Line Treatment of Advanced Pancreatic Cancer: A Retrospective Monocentric Study
-
Published:2022-02
Issue:
Volume:Volume 14
Page:535-546
-
ISSN:1179-1322
-
Container-title:Cancer Management and Research
-
language:en
-
Short-container-title:CMAR
Author:
Zhang Feng,
Wang Yuyang,
Yang Fangfang,
Zhang Yuming,
Jiang Man,
Zhang XiaochunORCID
Publisher
Informa UK Limited
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献